Terug
32
7
Dagbereik
€ 12,88
€ 13,99
52-Weeksbereik
€ 3,92
€ 14,65
Volume
272.542
50D / 200D Gem.
€ 12,15
/
€ 8,61
Vorige Slotkoers
€ 13,66
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 69,9 | 0,4 |
| P/B | 7,3 | 2,9 |
| ROE % | 11,4 | 3,7 |
| Net Margin % | 14,6 | 3,9 |
| Rev Growth 5Y % | 15,4 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 30,00
+118.8%
Forward K/W
70,3
Forward WPA
€ 0,20
WPA Groei (sch.)
+0,0%
Omzet Sch.
66 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,28
€ 0,27 – € 0,29
|
110 M | 1 |
| FY2027 |
€ 0,28
€ 0,20 – € 0,39
|
81 M | 3 |
| FY2026 |
€ 0,20
€ 0,16 – € 0,26
|
66 M | 3 |
Belangrijkste Punten
Revenue grew 15,42% annually over 5 years — strong growth
Earnings grew 163,39% over the past year
ROE of 11,35% — decent returns on equity
Debt/Equity of 0,09 — conservative balance sheet
Generating 16,40M in free cash flow
P/E of 69,90 — premium valuation
Groei
Revenue Growth (5Y)
15,42%
Revenue (1Y)28,34%
Earnings (1Y)163,39%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
11,35%
ROIC4,08%
Net Margin14,62%
Op. Margin8,28%
Veiligheid
Debt / Equity
0,09
Current Ratio3,83
Interest Coverage1,96
Waardering
P/E Ratio
69,90
P/B Ratio7,34
EV/EBITDA109,38
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28,34% | Revenue Growth (3Y) | 28,69% |
| Earnings Growth (1Y) | 163,39% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15,42% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 52,64M | Net Income (TTM) | 7,69M |
| ROE | 11,35% | ROA | 6,81% |
| Gross Margin | 75,42% | Operating Margin | 8,28% |
| Net Margin | 14,62% | Free Cash Flow (TTM) | 16,40M |
| ROIC | 4,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 3,83 |
| Interest Coverage | 1,96 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 69,90 | P/B Ratio | 7,34 |
| P/S Ratio | 10,22 | PEG Ratio | 0,06 |
| EV/EBITDA | 109,38 | Dividend Yield | 0,00% |
| Market Cap | 537,75M | Enterprise Value | 476,61M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 52,64M | 41,02M | 31,79M | 27,18M | 29,66M |
| Net Income | 7,69M | 2,92M | -4,20M | -13,35M | -6,46M |
| EPS (Diluted) | 0,36 | 0,09 | -0,13 | -0,43 | -0,21 |
| Gross Profit | 39,70M | 30,58M | 23,48M | 20,05M | 23,06M |
| Operating Income | 4,36M | 1,39M | -4,96M | -12,68M | -5,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 112,92M | 94,32M | 62,97M | 64,48M | 75,73M |
| Total Liabilities | 34,67M | 32,00M | 21,39M | 19,08M | 18,41M |
| Shareholders' Equity | 73,22M | 62,31M | 41,58M | 45,40M | 57,33M |
| Total Debt | 6,82M | 5,62M | 471.000,0 | 488.000,0 | 754.000,0 |
| Cash & Equivalents | 67,95M | 69,35M | 10,52M | 47,58M | 16,92M |
| Current Assets | 84,89M | 79,67M | 55,47M | 58,09M | 65,45M |
| Current Liabilities | 22,16M | 15,35M | 9,76M | 8,14M | 9,07M |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#776 of 1024
Custom
Full Throttle
#144 of 146
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Full Throttle
Mar 24, 2026